Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
14.31
Price to sales ratio
5.28

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1450
EWTX
Edgewise Therapeutics, Inc. - Common Stock
39.73 USD-3.73%-7.54%+11.26%+160.87%4.27 B USD
1529
NAMS
NewAmsterdam Pharma Company N.V. - Ordinary Shares
33.29 USD+0.03%-9.19%+8.97%-8.22%3.89 B USD
1554
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.02 USD+0.46%-4.09%+14.20%+74.64%3.73 B USD
1568
RLAY
Relay Therapeutics, Inc. - Common Stock
19.08 USD+1.87%-3.20%+27.28%+437.46%3.66 B USD

Frequently asked questions about Catalyst Pharmaceuticals, Inc. - Common Stock

What is the Catalyst Pharmaceuticals, Inc. - Common Stock stock price today?

The current price of Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) is 31.49. Over the past 24 hours, the stock has changed by +0.03%. Follow the CPRX chart for real-time price dynamics.

What is the stock ticker of Catalyst Pharmaceuticals, Inc. - Common Stock?

Catalyst Pharmaceuticals, Inc. - Common Stock trades under the ticker CPRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Catalyst Pharmaceuticals, Inc. - Common Stock stock going up?

CPRX has changed by +0.06% over the last week, +0.41% over the last month, and +48.47% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Catalyst Pharmaceuticals, Inc. - Common Stock net income for the last quarter?

Catalyst Pharmaceuticals, Inc. - Common Stock reported net income of 63.73 M for the last quarter. The previous quarter showed 52.7 M, which means net income changed by +20.94%.

How many employees does Catalyst Pharmaceuticals, Inc. - Common Stock have?

As of the latest available data, Catalyst Pharmaceuticals, Inc. - Common Stock has 182 employees. Workforce size can provide additional context about the company's scale and operations.

What is Catalyst Pharmaceuticals, Inc. - Common Stock EBITDA?

Catalyst Pharmaceuticals, Inc. - Common Stock EBITDA is 92.71 M, and its EBITDA margin is 62.06%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Catalyst Pharmaceuticals, Inc. - Common Stock stock?

You can buy Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Catalyst Pharmaceuticals, Inc. - Common Stock stock?

Investing in Catalyst Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CPRX chart and related analysis on metatrader.com as part of your research.

News